One recent study shows that chemical activators of PERK have high therapeutic potential for ER stress-associated diseases40, supporting the possibility that targeting ERICA may be a promising neuroprotective strategy for neurodegenerative diseases. This evidence concerns the gene EIF2AK3 and neurodegenerative disease.